T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$762M |
| 2 |
PTC
PTC
|
+$631M |
| 3 |
Humana
HUM
|
+$400M |
| 4 |
DTE Energy
DTE
|
+$377M |
| 5 |
Exelon
EXC
|
+$376M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$892M |
| 2 |
Apple
AAPL
|
+$812M |
| 3 |
Danaher
DHR
|
+$508M |
| 4 |
Microsoft
MSFT
|
+$492M |
| 5 |
Intercontinental Exchange
ICE
|
+$460M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 21.9% |
| 3 | Financials | 12% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Industrials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
PRA Group
PRAA
$775M
| $64.6M | 0.05% |
3,364,177
-210,111
| -6% | -$4.42M |
|
327
Colliers International
CIGI
$5.28B
| $64.5M | 0.05% |
+677,529
| New | +$72.8M |
|
328
Amplitude
AMPL
$1.57B
| $64.5M | 0.05% |
5,576,286
+287,319
| +5% | +$3.32M |
|
329
Voya Financial
VOYA
$9.12B
| $64.2M | 0.05% |
965,593
+119,948
| +14% | +$8.54M |
|
330
LCI Industries
LCII
$2.61B
| $64.1M | 0.05% |
545,891
-224
| -0% | -$28.1K |
|
331
Carpenter Technology
CRS
$27B
| $63.4M | 0.04% |
943,114
-470
| -0% | -$28.5K |
|
332
Belden
BDC
$5.39B
| $63.2M | 0.04% |
654,817
-352,144
| -35% | -$32.9M |
|
333
Toro Company
TTC
$9.27B
| $62.7M | 0.04% |
754,337
+84,698
| +13% | +$8.16M |
|
334
Maplebear
CART
$11.4B
| $62M | 0.04% |
+2,088,417
| New | +$63.3M |
|
335
Pacific Biosciences
PACB
$354M
| $61.9M | 0.04% |
7,415,524
+1,243,925
| +20% | +$14.2M |
|
336
Group 1 Automotive
GPI
$3.13B
| $61.6M | 0.04% |
229,353
| – | – |
|
|
SRCL
337
DELISTED
Stericycle Inc
SRCL
| $61.5M | 0.04% |
1,375,610
-3,995
| -0.3% | -$178K |
|
338
Vaxcyte
PCVX
$8.87B
| $61.4M | 0.04% |
1,204,628
+61,710
| +5% | +$3.04M |
|
339
Orion
OEC
$365M
| $61.3M | 0.04% |
2,880,482
-44,070
| -2% | -$962K |
|
|
CFB
340
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $61.1M | 0.04% |
6,055,487
-114,022
| -2% | -$1.24M |
|
341
DT Midstream
DTM
$13.8B
| $60.7M | 0.04% |
+1,147,422
| New | +$59.9M |
|
342
Enpro
NPO
$7.21B
| $60.6M | 0.04% |
499,734
-238
| -0% | -$31.3K |
|
|
CFLT
343
DELISTED
Confluent
CFLT
| $59.7M | 0.04% |
2,014,733
-24,700
| -1% | -$828K |
|
344
Dollar General
DG
$27.1B
| $58.9M | 0.04% |
556,741
-747,945
| -57% | -$111M |
|
345
Utz Brands
UTZ
$1.25B
| $58.4M | 0.04% |
4,352,059
-1,148
| -0% | -$17.7K |
|
346
FTI Consulting
FCN
$4.17B
| $57.7M | 0.04% |
323,684
-28
| -0% | -$5.22K |
|
347
Toast
TOST
$19.9B
| $57.3M | 0.04% |
3,061,406
-260,806
| -8% | -$5.66M |
|
348
James River Group Holdings
JRVR
$203M
| $56.1M | 0.04% |
3,656,491
+60,968
| +2% | +$994K |
|
349
NOV
NOV
$7.38B
| $55.7M | 0.04% |
+2,665,646
| New | +$53M |
|
|
SASR
350
DELISTED
Sandy Spring Bancorp Inc
SASR
| $54.6M | 0.04% |
2,549,818
+10,806
| +0.4% | +$247K |
|
Similar funds
T. Rowe Price Investment Management's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Investment Management held 604 positions worth $141B, down 3.6% from $147B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Investment Management's Q3 2023 filing shows 38 new, 233 increased, 256 reduced and 33 closed positions. Its largest new stake was Ulta Beauty: 509,246 shares worth $203M. The largest sale was Black Knight, Inc. Common Stock, an estimated $892M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Investment Management's largest Q3 2023 buy was Ulta Beauty: 509,246 shares worth $203M.
- T. Rowe Price Investment Management added most to RTX Corp in Q3 2023, an estimated $762M increase.
- T. Rowe Price Investment Management's biggest Q3 2023 reduction was Apple, cutting an estimated $812M.
- T. Rowe Price Investment Management fully exited Black Knight, Inc. Common Stock in Q3 2023, selling an estimated $892M.
- T. Rowe Price Investment Management's ten largest holdings make up 16% of its $141B portfolio in Q3 2023.
- T. Rowe Price Investment Management opened 38 new positions and closed 33 in Q3 2023.
- T. Rowe Price Investment Management's portfolio value fell 3.6% quarter-over-quarter to $141B.
Based on T. Rowe Price Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.